首页> 外文期刊>RSC Advances >Relative quantification of neuronal polar lipids by UPLC-MS reveals the brain protection mechanism of Danhong injection
【24h】

Relative quantification of neuronal polar lipids by UPLC-MS reveals the brain protection mechanism of Danhong injection

机译:UPLC-MS对神经元极性脂质的相对定量揭示了丹红注射液的脑保护机制

获取原文
获取外文期刊封面目录资料

摘要

Promising results from clinical trials have fueled a growing acceptance of Danhong injection (DHI) as a Chinese Materia Medica standardized product for the treatment of ischemic stroke. However, little information is available on the underlying mechanisms of DHI especially in lipidomics. In this study, experiments on permanent middle cerebral artery occlusion (MCAO) in mice were carried out to confirm the protective effect of DHI. Furthermore, primary mouse cortical neurons subjected to oxygen-glucose-deprivation (OGD) were used to investigate the protective mechanisms of DHI. A UPLC-MS profiling analysis for neuronal polar lipids including phosphatidylcholines (PCs), sphingomyelins (SMs) and ceramides (Cers) was carried out in order to study the potential biomarkers in this OGD-induced neuron injury model. The results showed that pretreatment with DHI resulted in a significantly smaller infarct volume and better neurological scores than pretreatment with saline in MCAO mice. In an OGD-induced neuron injury model, DHI exhibited remarkable neuroprotection by reducing the neuronal damage and excessive accumulation of intracellular reactive oxygen species, suppressing intracellular free calcium influx and apoptosis. Meanwhile, 28 biomarkers of PCs, SMs and Cers sub-species of neuronal injury induced by OGD have been identified for the first time. The perturbations could be partly reversed by DHI intervention such as PC (17:0,0:0), PC (18:0,0:0), PC (16:0,0:0), PC (P-16:0,0:0) and SM (18:0,16:0). The results specifically provide information on the relationships between PCs, SMs, Cers sub-species and neuronal damage mechanisms during an ischemic stroke. Overall, we found that the therapeutic effects of DHI on cerebral ischemia are partially due to interferences with the PC and SM metabolisms.
机译:临床试验的有希望的结果推动了丹红注射液(DHI)作为治疗缺血性中风的中药标准化产品的日益增长的接受度。但是,关于DHI的潜在机制(尤其是脂质组学)的信息很少。在这项研究中,进行了小鼠永久性大脑中动脉阻塞(MCAO)的实验,以确认DHI的保护作用。此外,经历氧-葡萄糖剥夺(OGD)的原代小鼠皮质神经元被用来研究DHI的保护机制。为了研究这种OGD诱导的神经元损伤模型中的潜在生物标志物,对包括磷脂酰胆碱(PCs),鞘磷脂(SMs)和神经酰胺(Cers)在内的神经元极性脂质进行了UPLC-MS分析分析。结果表明,用DHI预处理比MCAO小鼠用盐水预处理可显着减小梗塞体积并改善神经系统评分。在OGD诱导的神经元损伤模型中,DHI通过减少神经元损伤和细胞内活性氧的过度积累,抑制细胞内游离钙的内流和凋亡而表现出显着的神经保护作用。同时,首次鉴定了由OGD引起的神经元损伤的PC,SM和Cers亚种的28种生物标记。 DHI干预可能会部分抵消干扰,例如PC(17:0,0:0),PC(18:0,0:0),PC(16:0,0:0),PC(P-16: 0,0:0)和SM(18:0,16:0)。结果特别提供了有关缺血性中风中PC,SM,Cers亚种与神经元损伤机制之间关系的信息。总的来说,我们发现DHI对脑缺血的治疗作用部分归因于PC和SM代谢的干扰。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号